Probiotics and nutraceuticals as a new frontier in obesity prevention and management

Article ID	Journal	Published Year	Pages	File Type
8629879	Diabetes Research and Clinical Practice	2018	10 Pages	PDF

Abstract

Probiotics and nutraceuticals led to a significantly lower prevalence of obesity, reduction of insulin resistance, total and VAT weight. Our study demonstrated that supplementation of probiotics with omega-3 may have the most beneficial antiobesity properties.

Keywords

PPAR NAFLD TGF-β BSH INF-γ GLP FXR HDL-C LDL-C ACAT SCFA HFD CFU SREBP1c WPI LPS FAS MSG farnesoid X receptor fatty acid synthase Short-chain fatty acids interferon γ interleukins visceral adipose tissue non-alcoholic fatty liver disease Transforming growth factor β Triglycerides high-fat diet zonula occludens Gum arabic lipopolysaccharide VAT Insulin resistance Bile salt hydrolase colony-forming unit sterol regulatory element-binding protein 1c Whey protein isolate total cholesterol high density lipoproteins cholesterol Low density lipoproteins cholesterol monosodium glutamate Glucagon-Like Peptides peroxisome proliferator-activated receptor